Positioning no disclosures inside 60 days, left as found
Options put/call open interest 11.39, read 2026-11-02
Ethical does not pass the values gate
Price10.48 USD
Fair valueUnder review
Ethical score10.0/100
Our investment reviews on this name
2026-10-11Read Markdown14.55-28.0% to today ✓Accumulation gives way to Markdown after a 13% slide in 5 weeks
2026-09-04Read Accumulation16.66-37.1% to today Distribution gives way to Accumulation after a 35% rise in 4 weeks
2026-08-04Read Distribution12.34-15.1% to today ✓Markup gives way to Distribution after a 58% slide in 5 weeks
2026-07-02Read Markup29.36-64.3% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Intuitive Machines, Inc. holds its Markdown at $10.48. Consolidating, no directional conviction, held for 57 days.
As held on the ledger · 2026-11-03
Phase
Markdown · caution
Quantitative state
Consolidating, no directional conviction, held for 57 days
Price at the screen
$10.48
Valuation
N/A trailing · -67.61 forward price to earnings
Values screen
FAIL· score 10.0
Beta
1.91
The Workings
Five Screens, Shown in Full
Does not pass. Business activity
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Prohibited sector: defense
Fail
Debt load
0.00%
Below 33%
Interest-bearing debt is just 0.0% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Revenue purity
7.37%
Below 5%
7.4% of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Intuitive Machines, does not clear the screen at the business-activity stage. It operates in aerospace and defense, so the financial ratios are not the deciding factor here.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when LUNR's ethical verdict changes
Today LUNR does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Fair value under review. Our model's value is 2.48x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-03 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
The moonshot that isn't for us
Intuitive Machines is a genuine moonshot — literally, a company landing hardware on the lunar surface, with revenue nearly tripling as the space economy takes off. It is exactly the kind of story that lights up a finance-channel highlight reel. It is also not something our screen will pass.
It fails on two counts. It does not yet make money, so a valuation built on it leans on hope more than cash flow. And its business activity does not clear our ethical screen. Add a weak competitive moat in a field crowded with better-funded rivals, and you have the kind of risk investors routinely underestimate when a story is this exciting.
We flag it AVOID not because space isn't the future — it may well be — but because "exciting" and "investable on our standards" are two different questions, and our job is to keep them apart. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
LUNR trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-01Markdown$10.67-0.7%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 138%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (9 analysts) rates it buy, with a mean price target of $38.
2026-10-25Markdown$10.74-11.8%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 11.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 138%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (9 analysts) rates it buy, with a mean price target of $38.
2026-10-18Markdown$12.18-16.3%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 16.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 114% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 138%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (9 analysts) rates it buy, with a mean price target of $38.
2026-10-11Markdown · changed$14.55+0.0%Entry 7
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 114% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 138%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (9 analysts) rates it buy, with a mean price target of $38.
2026-10-02Accumulation$14.55-12.7%Entry 6
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 12.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 114% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 138%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (9 analysts) rates it buy, with a mean price target of $38.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 35.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 114% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 138%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (9 analysts) rates it buy, with a mean price target of $38.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 8.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 114% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 138%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (9 analysts) rates it buy, with a mean price target of $38.
2026-07-18Markup$13.52-54.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 54.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 114% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 138%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (9 analysts) rates it buy, with a mean price target of $38.
2026-07-03Markup$29.36+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$29.36Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.